Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02202590 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Using Spectrally Encoded Confocal Microscopy (SECM) to Image the Esophagus

StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 11 months later Dec 2026 → Dec 2028
See other at-risk trials from Massachusetts General Hospital

Record History

  1. Primary completion pushed from Dec 2026 to Dec 2028 Completion pushed from Dec 2028 to Dec 2030 · Eligibility criteria expanded, about 8 words Show 2 more changesShow less
    • Completion pushed from Dec 2028 to Dec 2030
    • Eligibility criteria expanded, about 8 words
  2. Primary completion date: Dec 2025 to Dec 2026 Enrollment target: 84 to 96 · Completion date: Dec 2027 to Dec 2028 · Eligibility criteria expanded, about 12 words · 1 morev14 Show 4 more changesShow less
    • Enrollment target: 84 to 96
    • Completion date: Dec 2027 to Dec 2028
    • Eligibility criteria expanded, about 12 words
    • Study description expanded, about 2 words

    See this version in full on ClinicalTrials.gov ↗

  3. Primary completion date: Dec 2023 to Dec 2025 Completion date: Dec 2024 to Dec 2027v13 Show 1 more changeShow less
    • Completion date: Dec 2024 to Dec 2027
  4. Primary completion date: Dec 2021 to Dec 2023 Completion date: Dec 2022 to Dec 2024v12 Show 1 more changeShow less
    • Completion date: Dec 2022 to Dec 2024
  5. Primary endpoints revised (2)v11 See this version in full on ClinicalTrials.gov ↗
Show 9 earlier versionsHide 9 earlier versions
  1. Primary completion date: Dec 2019 to Dec 2021 Primary endpoints: 1 to 2 · Trial status: Recruiting to Active, Not Recruiting · Enrollment target: 72 to 84 · 3 morev10 Show 6 more changesShow less
    • Primary endpoints: 1 to 2
    • Trial status: Recruiting to Active, Not Recruiting
    • Enrollment target: 72 to 84
    • Completion date: Dec 2019 to Dec 2022
    • Secondary endpoints shortened, about 18 words
    • Site details revised

    See this version in full on ClinicalTrials.gov ↗

  2. Primary completion date: Jun 2019 to Dec 2019 Completion date: Jul 2019 to Dec 2019v9 Show 1 more changeShow less
    • Completion date: Jul 2019 to Dec 2019
  3. Primary completion date: Oct 2018 to Jun 2019 Completion date: Dec 2018 to Jul 2019v8 Show 1 more changeShow less
    • Completion date: Dec 2018 to Jul 2019
  4. Phase: Phase 1 to Not applicablev7
  5. Enrollment target: 36 to 72 Primary completion date: Oct 2017 to Oct 2018 · Completion date: Oct 2017 to Dec 2018 · Study description revisedv6 Show 3 more changesShow less
    • Primary completion date: Oct 2017 to Oct 2018
    • Completion date: Oct 2017 to Dec 2018
    • Study description revised

    See this version in full on ClinicalTrials.gov ↗

  6. 2 versions Re-verified since Oct 26, 2016, no change to tracked fieldsv4-v5
  7. Primary and study completion dates: Oct 2015 to Oct 2017 Primary endpoints: 2 to 1 · Secondary endpoints expanded, about 18 words · Collaborators: 1 to 2 · 1 morev3 Show 4 more changesShow less
    • Primary endpoints: 2 to 1
    • Secondary endpoints expanded, about 18 words
    • Collaborators: 1 to 2
    • Eligibility criteria expanded, about 3 words

    See this version in full on ClinicalTrials.gov ↗

  8. Eligibility criteria expanded, about 3 wordsv2 See this version in full on ClinicalTrials.gov ↗
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this study is to test the feasibility and the tolerability of a tethered spectrally encoded confocal microscopy (SECM) capsule and to use it to image the esophagus.
Trial Details
NCT Number NCT02202590
Lead Sponsor Massachusetts General Hospital
Collaborators: National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions Eosinophilic Esophagitis
Enrollment 96 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov